Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

December 9, 2008

Antibody Test Not the Best for Diagnosing Acute Hep C

People with HIV may take longer to develop hepatitis C virus (HCV) antibodies after becoming infected with the liver-damaging virus than HIV-negative patients, according to a study published in the January 2 issue of AIDS. The delay in antibody development lowers the number of HIV-positive patients who could be diagnosed during acute HCV infection, when treatment success rates are higher.

HCV is curable, but treatment success rates in people infected with both HCV and HIV are typically less than 40 percent. If doctors begin HCV treatment during the first few months after HCV infection, however, the chances of a cure increase substantially. In HIV-negative patients, the standard methods for detecting acute infection are the combination of elevated liver enzymes and a positive HCV antibody test.

To determine the most effective methods for diagnosing acute infection in HIV-positive patients, Emma Thomson, MRCP, and her colleagues from the Imperial College in London, examined blood samples from 43 patients from the St. Mary’s Acute Hepatitis C Cohort. Thomson and her colleagues checked the patients’ blood for levels of the liver enzyme alanine aminotransferase (ALT) and for the presence of HCV by polymerase chain reaction (PCR) test and an HCV antibody test.

Thomson’s team found that the HIV-positive men in the study had delayed development of HCV antibodies compared with HIV-negative patients. Most HIV-negative people will develop HCV antibodies within eight weeks of hepatitis infection, and nearly all have antibodies within six months of infection. Among the HIV-positive study volunteers, the average length of time to develop antibodies was three months, with two volunteers taking more than one year to develop antibodies.

PCR testing combined with ALT measurements offered a far more rapid and accurate method for detecting acute HCV infection, the authors concluded. In turn, they recommend PCR testing for HIV-positive patients suspected of acute HCV infection so that HCV treatment can be started quicker, affording a greater chance of treatment success.

Search: hepatitis c virus, HCV, hep c, acute, coinfection, Emma Thomson, Imperial College, St. Mary's Acute Hepatitis C Cohort


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy